{"disease":{"id":"ccr5","name":"ccr5"},"drugs":{"marketed":[{"drug_id":"maraviroc","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selzentry","generic_name":"MARAVIROC","company_name":"GSK","drug_phase":"marketed","molecular_target":"C-C chemokine receptor type 5","drug_class":"CCR5 Co-receptor Antagonist [EPC]","quality_score":75,"revenue":null,"mechanism":"Selzentry works by blocking the CCR5 receptor on immune cells, preventing HIV from entering and infecting these cells."},{"drug_id":"selzentry","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Selzentry","company_name":"Icahn School of Medicine at Mount Sinai","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, C-C chemokine receptor type 5, C-C chemokine receptor type 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00864474","title":"Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)","phase":"","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT05730673","title":"Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"CytoDyn, Inc.","has_results":false},{"nct_id":"NCT02990312","title":"Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}